Nov 15 2024 9 mins 2
Dr Mattsson and Dr Carsten Niemann, PhD, Clinical Ass. Prof. and Head of the CLL Research Laboratory at Rigshospitalet in Copenhagen, Denmark, discuss treatment considerations in CLL patients with comorbidities. This episode addresses questions such as; What to consider in patients who have high risk of infection, cardiovascular diseases, renal impairment and secondary primary malignancies? How important is the quality of life vs keeping the patients free from symptoms or adverse events?
